rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

National HealthCare Corporation

NHC · NYSE American

Health CareProviders & FacilitiesLeading

NHC stood above a rising 150-day average in 52 of the last 52 weekly readings, every one of them. It is 20.2% above that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
52 in a row
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$350K
Insider sales, 12 months
$20.1M
Officials’ trades on record
0
Institutions holding
229 (+14)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 52 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$6.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months20
Buyers · sellers1 · 9
WhoDidSharesTraded
Vicki L. DodsonSr.VP Patient Srvcssold4,834.001at $225.0022 Sep 2026filed 23 Sep 2026
Brian F. KiddSVP, CFOsold6,813at $225.7011 Sep 2026filed 14 Sep 2026
Josh A. McCrearySenior VP & General Counselsold571at $222.7310 Sep 2026filed 14 Sep 2026
Josh A. McCrearySenior VP & General Counselsold789at $223.7810 Sep 2026filed 14 Sep 2026
Josh A. McCrearySenior VP & General Counselsold1,291at $225.0910 Sep 2026filed 14 Sep 2026
Josh A. McCrearySenior VP & General Counselsold68at $225.5910 Sep 2026filed 14 Sep 2026
Ben Anderson Flatt, Sr.Senior VP & CIOsold1,000at $222.5028 Aug 2026filed 2 Sep 2026
David R. GiffordDirectorsold1,779at $225.4225 Aug 2026filed 28 Aug 2026
Ben Anderson Flatt, Sr.Senior VP & CIOsold1,000at $227.0025 Aug 2026filed 2 Sep 2026
Ben Anderson Flatt, Sr.Senior VP & CIOsold1,000at $237.0020 Aug 2026filed 2 Sep 2026
Stephen Fowler FlattCEOsold1,500at $237.0819 Aug 2026filed 20 Aug 2026
Ben Anderson Flatt, Sr.Senior VP & CIOsold1,000at $237.1819 Aug 2026filed 2 Sep 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders229+14 on the quarter
New · exited41 · 27
Reported value$2.2B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20261,975,785$417.6M+80,535+4.2%
Morgan Stanley Institutional Investment Advisors LLCreduced · filed 13 Aug 20261,028,534$217.4M-10,270−1.0%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026929,692$196.5M-17,285−1.8%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026809,224$171.0M+19,803+2.5%
FIRST TRUST ADVISORS LPadded · filed 11 Aug 2026730,573$154.4M+200,271+37.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026552,136$116.7M+2,588+0.5%
STATE STREET CORPadded · filed 7 Aug 2026526,732$111.7M+35,157+7.2%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026380,934$80.5M+57,667+17.8%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 2026299,717$63.3M-35,800−10.7%
Invesco Ltd.added · filed 14 Aug 2026175,290$37.0M+25,094+16.7%
31 Mar 2023 – 30 Jun 2026
114170225Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Vicki L. Dodson Company insiderSr.VP Patient Srvcs · last 22 Sep 20260 · 1
Brian F. Kidd Company insiderSVP, CFO · last 11 Sep 20260 · 2
Josh A. McCreary Company insiderSenior VP & General Counsel · last 10 Sep 20260 · 1
Ben Anderson Flatt Sr. Company insiderSenior VP & CIO · last 28 Aug 20260 · 7
David R. Gifford Company insiderDirector · last 25 Aug 20260 · 1
Stephen Fowler Flatt Company insiderCEO · last 19 Aug 20260 · 5
Emil E. Hassan Company insiderDirector · last 22 Jun 20260 · 34
Robert G. Adams Company insiderDirector · last 8 Jun 20266 · 0
Lisa Piercey Company insiderDirector · last 1 Jun 20261 · 0
Richard F. Laroche Jr. Company insiderDirector · last 21 May 20265 · 11
Timothy J. Shelly Company insiderSr.VP Operations · last 19 May 20260 · 3
James Paul Abernathy Company insiderDirector · last 7 May 20262 · 56

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 20258.5%
Free cash flow marginFY 2025 · to 31 Dec 20259.8%
Return on capital employedFY 2025 · to 31 Dec 202510.1%
Cash conversionFY 2025 · to 31 Dec 2025154%
Debt to equityFY 2025 · to 31 Dec 20250.04×
Share count trendFY 2025 · to 25 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$92.8M
Free cash flowFY 2025 · to 31 Dec 2025$148.6M

Analyst forecasts

No analyst forecasts yet.